Drug firm Glenmark on Wednesday said it has received approval from the US health regulator to market a generic medication to treat conditions caused by too much acid production in the stomach. Glenmark Specialty SA has received final approval from the US Food & Drug Administration (USFDA) for Esomeprazole Magnesium delayed-release capsules, the drug maker said in a statement.
Glenmark Speclt Generic Esomeprazole Magnesium Receives Approval in US
Notice of Acquisition of Approval for Application for Partial Change of Manufacturing and Marketing Approval for Esomeprazole Capsules concerning the Addition of a Manufacturing Plant
Zhejiang Yongtai`s Generic Esomeprazole Magnesium Receives Approval in the U.S.
Enforcement Report - Week of November 29, 2023
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for esomeprazole magnesium for delayed-release oral suspension, 20 mg and 40 mg, the company said in a BSE filing on Thursday.
Zydus' Generic Esomeprazole Magnesium Receives Approval in the U.S.
Ajanta's Generic Naproxen, Esomeprazole Magnesium Receives Approval in the U.S.
Enforcement Report - Week of October 5, 2022
Enforcement Report - Week of May 18, 2022